Ranked #8,595 of 8,699 institutional investors
Lion Point Capital, LP
New York, NY
$14.6M
US stock portfolio at live prices · today −$177K (−1.20%)
Live prices, last trade 9:54 AM ET
- Value at quarter end (Q3 2026)
- $17.3M
- Change from Q2 2026
- −$3.6M (−17.43%)
- Positions
- 27 · 0 new, 1 sold out
- Filed
- Nov 16, 2026
Not counted in the ranking: none$3.3M of holdings we could not match to a US listing are included at their reported quarter-end value.
Holdings
Q3 2026 13F, live pricesFENC 9.94%PRAX 9.38%MLTX 5.09%CMPS 4.47%IRON 4.19%
| Stock | Shares | Value, live | % of portfolio | vs Q2 2026 |
|---|---|---|---|---|
| FENC Fennec Pharmaceuticals Inc. | 112,434 | $1.5M | 9.94% | Unchanged |
| PRAX Praxis Precision Medicines, Inc. | 4,450 | $1.4M | 9.38% | Unchanged |
| MLTX MoonLake Immunotherapeutics | 67,500 | $745K | 5.09% | Unchanged |
| CMPS COMPASS Pathways plc | 80,000 | $653K | 4.47% | Unchanged |
| IRON Disc Medicine, Inc. | 8,100 | $612K | 4.19% | Unchanged |
| VTRS Viatris Inc. | 27,700 | $551K | 3.77% | Unchanged |
| GERN Geron Corporation | 578,000 | $526K | 3.60% | Unchanged |
| BNTC Benitec Biopharma Inc. | 62,000 | $490K | 3.36% | Unchanged |
| AZTA Azenta, Inc. | 9,700 | $441K | 3.02% | Unchanged |
| SRPT Sarepta Therapeutics, Inc. | 28,500 | $406K | 2.78% | Unchanged |
| ARDX Ardelyx, Inc. | 128,650 | $390K | 2.67% | Unchanged |
| BBIO BridgeBio Pharma, Inc. | 5,000 | $389K | 2.66% | Unchanged |
| EWTX Edgewise Therapeutics, Inc. | 9,100 | $373K | 2.55% | Unchanged |
| KURA Kura Oncology, Inc. | 46,000 | $336K | 2.30% | Unchanged |
| SNDX Syndax Pharmaceuticals, Inc. | 36,000 | $328K | 2.24% | Unchanged |
| MIST Milestone Pharmaceuticals Inc. | 820,000 | $321K | 2.20% | Unchanged |
| HUMA Humacyte, Inc. | 650,000 | $320K | 2.19% | Unchanged |
| DYN Dyne Therapeutics, Inc. | 18,000 | $292K | 2.00% | Unchanged |
| CUE Cue Biopharma, Inc. | 52,928 | $251K | 1.71% | Unchanged |
| JANX Janux Therapeutics, Inc. | 19,000 | $196K | 1.34% | Unchanged |
| RGNX REGENXBIO Inc. | 26,600 | $190K | 1.30% | Unchanged |
| RCKT Rocket Pharmaceuticals, Inc. | 86,000 | $182K | 1.25% | Unchanged |
| INVA Innoviva, Inc. | 8,200 | $153K | 1.04% | Unchanged |
| MLYS Mineralys Therapeutics, Inc. | 10,500 | $148K | 1.01% | Unchanged |
| ARQT Arcutis Biotherapeutics, Inc. | 5,250 | $143K | 0.98% | Unchanged |
| MCRB Seres Therapeutics, Inc. | 31,570 | $41K | 0.28% | Unchanged |
| SPRB Spruce Biosciences, Inc. | 1,000 | $40K | 0.27% | Unchanged |
Sold out in Q3 2026
| Stock | Shares held at Q2 2026 | Worth today |
|---|---|---|
| LNTH Lantheus Holdings, Inc. | 5,500 | $562K |